Oral Oncology
Volume 38, Issue 7 , Pages 670-679 , October 2002

Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines

Received 21 December 2001 ,Accepted 16 January 2002.

References 

  1. Mann E, Spiro J, Chen L, Kreutzer D. Cytokines expression by head and neck squamous cell carcinoma. Am. J. Surg. 1992;164:567–573
  2. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, et al.  Expression of proinflammatory and proangiogenetic cytokines in patients with head and neck cancer. Clin. Cancer Res. 1999;5:1369–1379
  3. Choen RF, Contrino J, Spiro JD, Mann EA, Chen LL, Kreutzer DL. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch. Otolaryngol Head Neck Surg. 1995;121:202–209
  4. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu. Rev. Immunol. 1991;9:617–648
  5. Abruzzo LV, Thornton AJ, Liebert M, Grossman HB, Evanoff H, Westwick J, et al.  Cytokine-induced gene expression of intreleukin-8 in human transitional cell carcinomas and renal cell carcinomas. Am. J. Pathol. 1992;140:365–373
  6. Richards BL, Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am. J. Surg. 1997;174:507–512
  7. Wang J, Huang M, Lee P, Komanduri K, Sharma S, Chen G, et al.  Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. J. Interferon Cytokine Res. 1996;16:53–60
  8. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine. 2000;12:78–85
  9. Miller LJ, Kurtzmann SH, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res. 1998;18:77–81
  10. Olbina G, Cieslak D, Ruzdijic S, Esler C, An Z, Wang X, et al.  Reversible inhibition of IL-8 receptor B mRNA expression and proliferation in non-small cell lung cancer by antisense oligonucleotides. Anticancer Res. 1996;16:3525–3530
  11. Reiland J, Furcht LT, McCarthy JB. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate. 1999;41:78–88
  12. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, et al.  Interleukin 8 expression regulates tumorigenicity and metastasis in androgen-independent prostate cancer. Clin. Cancer Res. 2000;6:2104–2119
  13. Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol. 1997;151:1105–1113
  14. Youngs SJ, Ali SA, Taub DD, Rees RC. Chemokines induce migrational responses in human breast carcinoma cell lines. Int. J. Cancer. 1997;71:257–266
  15. Kitadai Y, Haruma K, Mukaida N, Ohmoto Y, Matsutani N, Yasui W, et al.  Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin. Cancer Res. 2000;6:2735–2740
  16. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 1994;54:3242–3247
  17. Fujisawa N, Sakao Y, Hayashi S, Hadden WA, Harmon CL, Miller EJ. alpha-Chemokine growth factors for adenocarcinomas; a synthetic peptide inhibitor for alpha-chemokines inhibits the growth of adenocarcinoma cell lines. J. Cancer Res. Clin. Oncol. 2000;126:19–26
  18. Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, et al.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am. J. Pathol. 1999;154:1503–1512
  19. Arenberg DA, Kunkel SL, Polverimi PJ, Glass M, Burdick MD, Strieter RM. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 1996;97:2792–2802
  20. Tomita T, Fujii M, Tokumaru Y, Imanishi Y, Kanke M, Yamashita T, et al.  Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells. Cancer Lett. 2000;156:83–91
  21. Rosenthal EL, Johnson TA, Allen ED, Apel IJ, Punturieri A, Weiss SJ. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Cancer Res. 1998;58:5221–5230
  22. Xie B, Bucana CD, Fidler IJ. Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. Am. J. Pathol. 1994;144:1058–1067
  23. Ikebe T, Takeuchi H, Jimi E, Beppu M, Shinohara M, Shirasuna K. Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma. Int. J. Cancer. 1998;77:578–585
  24. Mann EA, Hibbs MS, Spiro JD, Bowik C, Wang XZ, Clawson M, et al.  Cytokine regulation of gelatinase production by head and neck squamous cell carcinoma: the role of tumor necrosis factor-alpha. Ann. Otol. Rhinol. Laryngol. 1995;104:203–209
  25. Maruyama K, Zhang JZ, Nihei Y, Ono I, Kaneko F. Regulatory effects of gamma-interferon on IL-6 and IL-8 secretion by cultured human keratinocytes and dermal fibroblasts. J. Dermatol. 1995;22:901–906
  26. Singh RK, Varney ML. Regulation of interleukin 8 expression in human malignant melanoma cells. Cancer Res. 1998;58:1532–1537
  27. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, et al.  Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol. 1998;152:93–100
  28. Collins TS, Lee LE, Ting JP. Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanism. Cancer Immunol. Immunother. 2000;49:78–84
  29. Sozzani S, Locati D, Zhou D, Rieppi M, Luini W, Lamorse G, et al.  Receptor, signal transduction and spectrum of action of monocytic chemotactic protein 1 and related chemokines. J. Leukoc. Biol. 1995;57:788–794
  30. Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, et al.  Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res. 2000;60:2290–2299
  31. Hayashi H, Shimizu R, Fujii K, Itoh S, Yang D, Onozaki K. Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse. Int. J. Cancer. 1997;71:416–421
  32. Wilson AJ, Byron K, Gibson PR. Interleukin-8 stimulates the migration of human colonic epithelial cells in vitro. Clin. Sci. 1999;97:385–390
  33. Fujimoto J, Sakaguchi H, Aoki I, Tamaya T. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res. 2000;60:2632–2635
  34. Yatsunami J, Tsuruta N, Ogata K, Wakamatsu K, Takayama K, Kawasaki M, et al.  Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Lett. 1997;120:101–108
  35. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J. Biol. Chem. 1992;267:16283–16287
  36. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J. Immunol. 1995;155:2587–2594
  37. Loukinova E, Dong G, Enamorado-Ayalya I, Thomas GR, Chen Z, Schreiber H, et al.  Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene. 2000;19:3477–3486
  38. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY, et al.  Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Invest. 1998;102:465–472
  39. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al.  The functional role of the ERL motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 1995;270:27348–27357
  40. Ohashi K, Nemoto T, Nakamura K, Nemori R. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer. 2000;88:2201–2209
  41. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsumoto K, Kusano M, et al.  Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res. 1999;59:3313–3316
  42. Meade-Tollin LC, Boukamp P, Fusenig NE, Bowen CP, Tsang TC, Bowden GT. Differntial expression of matrix metalloprotinases in activated c-ras-Ha-transfected immortalized human keratinocytes. Br. J. Cancer. 1998;77:724–730

PII: S1368-8375(02)00006-4

Oral Oncology
Volume 38, Issue 7 , Pages 670-679 , October 2002

Article Tools

* Image Usage & Resolution